SCHEMBL7698276

SCHEMBL7698276

O=C(NCc1ccccc1Cl)[C@H]1CC[C@H](Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
LMNA P02545 2/20 0.52
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
POLB P06746 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
LPAR2 Q9HBW0 1/20 0.47
P2RX7 Q99572 1/20 0.46
KDM4E B2RXH2 1/20 0.45
THRB P10828 1/20 0.45
TP53 P04637 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698279 1.00 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL7696480 0.89 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2NPC1RAB9APOLB
SCHEMBL7692144 0.89 LMNA (0.55) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL7696476 0.89 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2NPC1RAB9APOLB
SCHEMBL7692146 0.89 LMNA (0.55) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL7658865 0.88 SMN1; SMN2 (0.54) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL7197538 0.88 SMN1; SMN2 (0.54) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL7697363 0.87 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL7695718 0.87 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL7691713 0.86 HPGD (0.58) ALDH1A1SMN1; SMN2LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed